Vaccine Technology: Adjuvants for Increased Efficacy
- 1 October 1987
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 5 (10) , 1041-1045
- https://doi.org/10.1038/nbt1087-1041
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursorCell, 1987
- An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunityJournal of Immunological Methods, 1986
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985
- HLA‐B27, Klebsiella and Ankylosing Spondylitis: Biological and Chemical StudiesImmunological Reviews, 1983
- The Follicular Dendritic Cell: Its Role in Antigen Presentation in the Generation of Immunological MemoryImmunological Reviews, 1980
- A review of block polymer surfactantsJournal of Oil & Fat Industries, 1977
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974